Cargando…

Clinical Features and Body Composition in Men with Hormone-Sensitive Metastatic Prostate Cancer: A Pilot Study Examining Differences by Race

Black men treated with frontline therapies for metastatic prostate cancer (MPC) show better clinical outcomes than non-Black men receiving similar treatments. Variations in body composition may contribute to these findings. However, preliminary data are required to support this concept. We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheean, Patricia M., O'Connor, Paula, Joyce, Cara, Vasilopoulos, Vasilios, Badami, Ami, Stolley, Melinda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184233/ https://www.ncbi.nlm.nih.gov/pubmed/35693376 http://dx.doi.org/10.1155/2022/9242243

Ejemplares similares

Circulating miRNAs as early indicators of diet and physical activity response in women with metastatic breast cancer
por: Olson, Jessica, et al.
Publicado: (2021)

Analysis of Circulating Immune Biomarkers by Race in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Sipuleucel-T
por: Hawley, Jessica E, et al.
Publicado: (2021)

Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer
por: George, Daniel J., et al.
Publicado: (2021)

Outcomes of Older Men Receiving Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer
por: Lage, Daniel E., et al.
Publicado: (2021)

Study design and protocol for moving forward: a weight loss intervention trial for African-American breast cancer survivors
por: Stolley, Melinda R., et al.
Publicado: (2015)

Sex hormones in Malay and Chinese men in Malaysia: are there age and race differences?
por: Chin, Kok-Yong, et al.
Publicado: (2013)

Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men
por: Nakagawa, Ryunosuke, et al.
Publicado: (2022)

A Pilot Trial of Pembrolizumab plus Prostatic Cryotherapy for Men with Newly Diagnosed Oligometastatic Hormone-Sensitive Prostate Cancer
por: Ross, Ashley E., et al.
Publicado: (2019)

Preadamite Races of Men
por: Byrd, Harvey L.
Publicado: (1881)

Interactive Mobile Phone HIV Adherence Support for Men Who Have Sex With Men in the Philippines Connect for Life Study: Mixed Methods Approach to Intervention Development and Pilot Testing
por: O'Connor, Cara, et al.
Publicado: (2022)

Examining the Association of Pain and Financial Hardship Among Older Men by Race in the United States
por: Song, Chiho, et al.
Publicado: (2021)

Cytoreductive surgery for men with metastatic prostate cancer
por: Katelaris, Nikolas, et al.
Publicado: (2016)

Examining the Impact of Race on Motivational Interviewing Implementation and Outcomes with HIV+ Heavy Drinking Men Who Have Sex with Men
por: Surace, Anthony, et al.
Publicado: (2022)

The impact of race on survival in metastatic prostate cancer: a systematic literature review
por: Freedland, Stephen J., et al.
Publicado: (2023)

Exercise as Medicine: Can We Preserve Cardiac Health Through Physical Activity?
por: Stolley, Melinda R., et al.
Publicado: (2023)

Depression, Nutrition, and Adherence to Antiretroviral Therapy in Men Who Have Sex With Men in Manila, Philippines
por: Elsayed, Hend, et al.
Publicado: (2021)

Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate Cancer
por: Fradin, James, et al.
Publicado: (2023)

Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?
por: Onal, Cem
Publicado: (2019)

ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer
por: Sheill, Gráinne, et al.
Publicado: (2023)

Retrospective validation of bone risk stratification criteria for men with de novo metastatic hormone-naive prostate cancer in China
por: Zhang, Yang, et al.
Publicado: (2023)

Satraplatin in the treatment of hormone-refractory metastatic prostate cancer
por: Armstrong, Andrew J, et al.
Publicado: (2007)

Advancements in the treatment of metastatic hormone-sensitive prostate cancer
por: Li, Hengping, et al.
Publicado: (2022)

Race/ethnic differences in bone mineral densities in older men
por: Nam, H.-S., et al.
Publicado: (2010)

Suicidal ideation in men during COVID-19: an examination of protective factors
por: Seidler, Zac E., et al.
Publicado: (2023)

The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.
por: Fosså, S. D., et al.
Publicado: (1992)

Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
por: Rydzewska, Larysa H.M., et al.
Publicado: (2017)

Long term health consequences of a career in professional horse racing: the prevalence of pain amongst retired race jockeys
por: Tomkinson, A, et al.
Publicado: (2012)

Circulating tumor cell count during zoledronic acid treatment in men with metastatic prostate cancer: a pilot study
por: Ide, Hisamitsu, et al.
Publicado: (2014)

Hormonal Therapy in Metastatic Prostate Cancer: Current Perspectives and Controversies
por: Garg, Manish, et al.
Publicado: (2013)

Role of systemic chemotherapy in metastatic hormone-sensitive prostate cancer
por: Shenoy, Niraj, et al.
Publicado: (2016)

Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
por: Cattrini, Carlo, et al.
Publicado: (2019)

Metastatic hormone-sensitive prostate cancer: How should it be treated?
por: López-Campos, Fernando, et al.
Publicado: (2021)

Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate Cancer
por: Lee, Arnold
Publicado: (2023)

Impact of Comorbidity, Race, and Marital Status in Men Referred for Prostate Biopsy with PSA >20 ng/mL: A Pilot Study in High-Risk Patients
por: Klaassen, Zachary, et al.
Publicado: (2014)

Relationship Between Meaningful Activity Engagement and Well-Being Moderated by Race
por: O'Connor, Dugan, et al.
Publicado: (2021)

What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis
por: Vale, C L, et al.
Publicado: (2018)

Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries
por: de Freitas, Hayley M., et al.
Publicado: (2019)

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
por: Armstrong, Andrew J., et al.
Publicado: (2019)

Characterising body composition and bone health in transgender individuals receiving gender‐affirming hormone therapy
por: Ford, Ky, et al.
Publicado: (2022)

Role of circulating tumor cell clusters in patients with metastatic hormone-sensitive prostate cancer receiving a gonadotropin-releasing hormone antagonist: A pilot study
por: Kohada, Yuki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u7e5dif9l1g7eh1ggrcv6orlg0